Close Menu

NEW YORK (GenomeWeb) – Twist Bioscience reported after the close of the market on Thursday that its first quarter revenues in fiscal year 2019 almost tripled versus the prior year period.

For the three months ended Dec. 31, 2018, the firm reported total revenues of $11.5 million, compared to $4.3 million for the same period in the previous year. It beat analysts' average revenue estimate of $9.7 million.

Twist's total revenues included $7.7 million from its synthetic biology business and $3.8 million from its genomics business.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Atlantic reports another SARS-CoV-2 testing problem may be lurking: backlogs.

Researchers have sequenced the genome of "the Methuselah of freshwater fish."

The US Biomedical Advanced Research and Development Authority is supporting efforts to develop vaccines against SARS-CoV-2.

In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.